AMS Quote, Financials, Valuation and Earnings

Biote has a net margin of -10.23% compared to American Shared Hospital Services's net margin of 28%. American Shared Hospital Services's return on equity of 4.81% beat Biote's return on equity of --.

American Shared Hospital Services has a consensus price target of $4.85, signalling upside risk potential of 90.95%. On the other hand Biote has an analysts' consensus of $6.40 which suggests that it could grow by 56.05%. Given that American Shared Hospital Services has higher upside potential than Biote, analysts believe American Shared Hospital Services is more attractive than Biote.

American Shared Hospital Services has a beta of 0.288, which suggesting that the stock is 71.223% less volatile than S&P 500. In comparison Biote has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

American Shared Hospital Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Biote offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. American Shared Hospital Services pays -- of its earnings as a dividend. Biote pays out 150.27% of its earnings as a dividend.

American Shared Hospital Services quarterly revenues are $6.1M, which are smaller than Biote quarterly revenues of $49M. American Shared Hospital Services's net income of -$625K is lower than Biote's net income of $13.7M. Notably, American Shared Hospital Services's price-to-earnings ratio is 11.55x while Biote's PE ratio is 6.72x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for American Shared Hospital Services is 0.58x versus 0.72x for Biote. Usually stocks with elevated PS ratios are considered overvalued.

Cryo-Cell International has a net margin of -10.23% compared to American Shared Hospital Services's net margin of 4.49%. American Shared Hospital Services's return on equity of 4.81% beat Cryo-Cell International's return on equity of --.

American Shared Hospital Services has a consensus price target of $4.85, signalling upside risk potential of 90.95%. On the other hand Cryo-Cell International has an analysts' consensus of $8.50 which suggests that it could grow by 73.12%. Given that American Shared Hospital Services has higher upside potential than Cryo-Cell International, analysts believe American Shared Hospital Services is more attractive than Cryo-Cell International.

American Shared Hospital Services has a beta of 0.288, which suggesting that the stock is 71.223% less volatile than S&P 500. In comparison Cryo-Cell International has a beta of 0.659, suggesting its less volatile than the S&P 500 by 34.131%.

American Shared Hospital Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cryo-Cell International offers a yield of 13.24% to investors and pays a quarterly dividend of $0.15 per share. American Shared Hospital Services pays -- of its earnings as a dividend. Cryo-Cell International pays out 502.5% of its earnings as a dividend.

American Shared Hospital Services quarterly revenues are $6.1M, which are smaller than Cryo-Cell International quarterly revenues of $7.9M. American Shared Hospital Services's net income of -$625K is lower than Cryo-Cell International's net income of $355.8K. Notably, American Shared Hospital Services's price-to-earnings ratio is 11.55x while Cryo-Cell International's PE ratio is 498.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for American Shared Hospital Services is 0.58x versus 1.27x for Cryo-Cell International. Usually stocks with elevated PS ratios are considered overvalued.

Omnicell has a net margin of -10.23% compared to American Shared Hospital Services's net margin of -2.6%. American Shared Hospital Services's return on equity of 4.81% beat Omnicell's return on equity of 1.73%.

American Shared Hospital Services has a consensus price target of $4.85, signalling upside risk potential of 90.95%. On the other hand Omnicell has an analysts' consensus of $43.33 which suggests that it could grow by 55.99%. Given that American Shared Hospital Services has higher upside potential than Omnicell, analysts believe American Shared Hospital Services is more attractive than Omnicell.

American Shared Hospital Services has a beta of 0.288, which suggesting that the stock is 71.223% less volatile than S&P 500. In comparison Omnicell has a beta of 0.761, suggesting its less volatile than the S&P 500 by 23.879%.

American Shared Hospital Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Omnicell offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. American Shared Hospital Services pays -- of its earnings as a dividend. Omnicell pays out -- of its earnings as a dividend.

American Shared Hospital Services quarterly revenues are $6.1M, which are smaller than Omnicell quarterly revenues of $269.7M. American Shared Hospital Services's net income of -$625K is higher than Omnicell's net income of -$7M. Notably, American Shared Hospital Services's price-to-earnings ratio is 11.55x while Omnicell's PE ratio is 60.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for American Shared Hospital Services is 0.58x versus 1.14x for Omnicell. Usually stocks with elevated PS ratios are considered overvalued.

P3 Health Partners has a net margin of -10.23% compared to American Shared Hospital Services's net margin of -5.49%. American Shared Hospital Services's return on equity of 4.81% beat P3 Health Partners's return on equity of -53.56%.

American Shared Hospital Services has a consensus price target of $4.85, signalling upside risk potential of 90.95%. On the other hand P3 Health Partners has an analysts' consensus of $8.00 which suggests that it could grow by 23.08%. Given that American Shared Hospital Services has higher upside potential than P3 Health Partners, analysts believe American Shared Hospital Services is more attractive than P3 Health Partners.

American Shared Hospital Services has a beta of 0.288, which suggesting that the stock is 71.223% less volatile than S&P 500. In comparison P3 Health Partners has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

American Shared Hospital Services has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. P3 Health Partners offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. American Shared Hospital Services pays -- of its earnings as a dividend. P3 Health Partners pays out -- of its earnings as a dividend.

American Shared Hospital Services quarterly revenues are $6.1M, which are smaller than P3 Health Partners quarterly revenues of $373.2M. American Shared Hospital Services's net income of -$625K is higher than P3 Health Partners's net income of -$20.5M. Notably, American Shared Hospital Services's price-to-earnings ratio is 11.55x while P3 Health Partners's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for American Shared Hospital Services is 0.58x versus 0.01x for P3 Health Partners. Usually stocks with elevated PS ratios are considered overvalued.